Abstract
Eating disorders are serious diseases affecting mostly young women during their reproductive years. Anorexia nervosa (AN) is characterized by severe underweight, intense fear of becoming fat, disturbed body perception, and amenorrhea. The diagnosis of bulimia nervosa (BN) is based on recurrent episodes of binge eating in combination with inappropriate compensatory behavior like self-induced vomiting. Although body weight often remains normal, menstrual disturbances are also common in BN. Amenorrhea in AN is usually ascribed to inhibition of the hypothalamic-pituitary-gonadal axis, resulting in low levels of estradiol. Functional hypothalamic amenorrhea (FHA) can be normalized once body weight is restored. If there is a lack of response to psychotherapy and nutritional counseling, hormone substitution can be considered to prevent consequences of estrogen deficiency. The transdermal route is then recommended to overcome the suppressive effect of oral estrogen on bone trophic factors like insulin-like growth factor I. In BN, different mechanisms of amenorrhea have been proposed including FHA due to temporary starvation. In addition, BN seems to be linked to polycystic ovary syndrome (PCOS) since elevated prevalence of polycystic ovaries, acne, and hirsutism as well as high serum levels of androgens have been observed in bulimic women. It has been suggested that androgens may promote bulimic behavior and antiandrogenic oral contraceptives may therefore be beneficial in BN. Amenorrhea in women with eating disorders should be carefully evaluated in order to offer proper treatment depending on the underlying cause.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Treasure J, Duarte TA, Schmidt U. Eating disorders. Lancet. 2020;395:899–911.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013.
Mustelin L, Silén Y, Raevuori A, Hoek HW, Kaprio J, Keski-Rahkonen A. The DSM-5 diagnostic criteria for anorexia nervosa may change its population prevalence and prognostic value. J Psychiatry Res. 2016;77:85–91.
Smink FRE, van Hoeken D, Hoek HW. Epidemiology, course, and outcome of eating disorders. Curr Opin Psychiatry. 2013;26(6):543–8.
Dobrescu SR, Dinkler L, Gillberg C, Råstam M, Gillberg C, Wentz E. Anorexia nervosa: 30-year outcome. Br J Psychiatry. 2019;22:1–8.
Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry. 2011;68:724–31.
Marucci S, Ragione LD, DeIaco G, Mococci T, Vicini M, Guastamacchia E, Triggiani V. Anorexia nervosa and comorbid psychopathology. Endocr Metab Immune Disord Drug Targets. 2018;18(4):316–24.
Riva G. Neurobiology of anorexia nervosa: serotonin dysfunctions link self-starvation with body image disturbances through an impaired body memory. Front Hum Neurosci. 2016;10:600.
Allaway HCM, Southmayd EA, De Souza MJ. The physiology of functional hypothalamic amenorrhea associated with energy deficiency in exercising women and in women with anorexia nervosa. Horm Mol Biol Clin Investig. 2016;25(2):91–119.
Hirschberg AL. Female hyperandrogenism and elite sport. Endocr Connect. 2020;9:R81–92.
Misra M, Klibanski A. Endocrine consequences of anorexia nervosa. Lancet Diabetes Endocrinol. 2014;2:581–92.
Müller TD, Föcker M, Holtkamp K, Herpertz-Dahlmann B, Hebebrand J. Leptin-mediated neuroendocrine alterations in anorexia nervosa: somatic and behavioral implications. Child Adolesc Psychiatr Clin N Am. 2009;18(1):117–29.
Muñoz-Calvo MT, Argente J. Nutritional and pubertal disorders. Endocr Dev. 2016;29:153–73.
Neale J, Pais SMA, Nicholls D, Chapman S, Hudson LD. What are the effects of restrictive eating disorders on growth and puberty and are effects permanent? A systematic review and meta-analysis. J Adolesc Health. 2020;66(2):144–56.
Kouba S, Lindholm C, Hällström T, Hirschberg AL. Pregnancy and neonatal outcomes in women with eating disorders—a prospective controlled study. Obstet Gynecol. 2005;105:255–60.
Mantel Ä, Hirschberg AL, Stephansson O. Association of maternal eating disorders with pregnancy and neonatal outcomes. JAMA Psychiatry. 2020;77(3):285–93.
Shufelt CL, Torbati T, Dutra E. Hypothalamic amenorrhea and the long-term health consequences. Semin Reprod Med. 2017;35:256–62.
Misra M, Klibanski A. Bone metabolism in adolescents with anorexia nervosa. J Endocrinol Investig. 2011;34(4):324–32.
Miller KK, Lee EE, Lawson EA, Misra M, Minihan J, Grinspoon SK, Gleysteen S, Mickley D, Herzog D, Klibanski A. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab. 2006;91:2931–7.
Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi M-L, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S. International Society for Clinical Densitometry 2007 adult and Pediatric Official Positions. Bone. 2008;43:1115–21.
Legroux-Gerot I, Vignau J, Collier F, Cortet B. Bone loss associated with anorexia nervosa. Joint Bone Spine. 2005;72:489–95.
Faje AT, Fazeli PK, Miller KK, Katzman DK, Ebrahimi S, Lee H, Mendes N, Snelgrove D, Meenaghan E, Misra M, Klibanski A. Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord. 2014;47(5):458–66.
Almeida M, Laurent MR, Dubois V, Claessens F, O’Brien CA, Bouillon R, Vanderschueren D, Manolagas SC. Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev. 2017;97:135–87.
Snow CM, Rosen CJ, Robinson TL. Serum IGF-I is higher in gymnasts than runners and predicts bone and lean mass. Med Sci Sports Exerc. 2000;32:1902–7.
Tauchmanovà L, Pivonello R, De Martino MC, Rusciano A, De Leo M, Ruosi C, Mainolfi C, Lombardi G, Salvatore M, Colao A. Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism. Eur J Endocrinol. 2007;157:359–66.
Rickenlund A, Thorén M, Carlström K, von Schoultz B, Hirschberg AL. Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. J Clin Endocrinol Metab. 2004;89:702–7.
Gordon CM, Ackerman KE, Berga SL, Kaplan JR, Mastorakos G, Misra M, Murad MH, Santoro NF, Warren MP. Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:1413–39.
Misra M, Prabhakaran R, Miller KK, Goldstein MA, Mickley D, Clauss L, Lockhart P, Cord J, Herzog DB, Katzman DK, Klibanski A. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab. 2008;93:1231–7.
Misra M, Katzman D, Miller KK, Mendes N, Snelgrove D, Russell M, Goldstein MA, Ebrahimi S, Clauss L, Weigel T, Mickley D, Schoenfeld DA, Herzog DB, Klibanski A. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res. 2011;26:2430–8.
Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 1991;72(2):374–81.
Hilbert A, Hoek HW, Schmidt R. Evidence-based clinical guidelines for eating disorders: international comparison. Curr Opin Psychiatry. 2017;30:423–37.
Fisher CA, Skocic S, Rutherford KA, Hetrick SE. Family therapy approaches for anorexia nervosa. Cochrane Database Syst Rev. 2019. Published online May 1. https://doi.org/10.1002/14651858.CD004780.pub4.
van den Berg E, Houtzager L, de Vos J, Daemen I, Katsaragaki G, Karyotaki E, Cuijpers P, Dekker J. Meta-analysis on the efficacy of psychological treatments for anorexia nervosa. Eur Eat Disord Rev. 2019;27:331–51.
Zeeck A, Herpertz-Dahlmann B, Friederich HC, Brockmeyer T, Resmark G, Hagenah U, Ehrlich S, Cuntz U, Zipfel S, Hartmann A. Psychotherapeutic treatment for anorexia nervosa: a systematic review and network meta-analysis. Front Psychiatry. 2018;9:158.
Hay PJ, Touyz S, Claudino AM, Lujic S, Smith CA, Madden S. Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders. Cochrane Database Syst Rev. 2019;1:CD010827.
Keel PK, Brown TA. Update on course and outcome in eating disorders. Int J Eat Disord. 2010;43:195–204.
Carter FA, McIntosh VV, Joyce PR, Frampton CM, Bulik CM. Bulimia nervosa, childbirth, and psychopathology. J Psychosom Res. 2003;55:357–61.
Steiger H, Bruce KR, Groleau P. Neural circuits, neurotransmitters, and behavior: serotonin and temperament in bulimic syndromes. Curr Top Behav Neurosci. 2011;6:125–38.
Kimmel MC, Ferguson EH, Zerwas S, Bulik CM, Meltzer-Brody S. Obstetric and gynecologic problems associated with eating disorders. Int J Eat Disord. 2016;49(3):260–75.
Münster K, Helm P, Schmidt L. Secondary amenorrhoea: prevalence and medical contact—a cross–sectional study from a Danish county. Br J Obstet Gynaecol. 1992;99:430–3.
Resch M, Szendei G, Haász P. Eating disorders from a gynecologic and endocrinologic view: hormonal changes. Fertil Steril. 2004;81(4):1151–3.
Gendall KA, Joyce PR, Carter FA, McIntosh VV, Bulik CM. Thyroid indices and treatment outcome in bulimia nervosa. Acta Psychiatr Scand. 2003;108(3):190–5.
Naessén S, Carlström C, Glant R, Jacobsson H, Hirschberg AL. Bone mineral density in bulimic women—influence of endocrine factors and previous anorexia. Eur J Endocrinol. 2006;155:245–51.
Hirschberg AL. Sex hormones, appetite and eating behaviour in women. Maturitas. 2012;71:248–56.
Azziz R, Carmina E, ZiJiang Chen Z, Dunaif A, Laven JSE, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
Hirschberg AL, Naessén S, Stridsberg M, Byström B, Holte J. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol Endocrinol. 2004;19:79–87.
Thannickal A, Brutocao C, Alsawas M, Morrow A, Zaiem F, Murad MH, Chattha AJ. Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Clin Endocrinol (Oxf). 2020;92(4):338–49.
McCluskey SE, Lacey JH, Pearce JM. Binge-eating and polycystic ovaries. Lancet. 1992;340:723.
Morgan JF, McCluskey SE, Brunton JN, Hubert Lacey J. Polycystic ovarian morphology and bulimia nervosa: a 9-year follow-up study. Fertil Steril. 2002;77(5):928–31.
Naessén S, Garoff L, Carlström K, Glant R, Hirschberg AL. Polycystic ovary syndrome in bulimic women—an evaluation based on the new diagnostic criteria. Gynecol Endocrinol. 2006;22:388–94.
Eriksson E. Behavioral effects of androgens in women. In: Steiner M, Yonkers KA, Eriksson E, editors. Mood disorders in women. London: Martin Dunitz; 2000. p. 233–46.
Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Curr Psychiatry Rep. 2017;19(11):83.
Abraham S. Sexuality and reproduction in bulimia nervosa patients over 10 years. J Psychosom Res. 1998;44(3–4):491–502.
Johansen N, Hirschberg AL, Moen MH. The role of testosterone in menopausal hormone treatment. What is the evidence? Acta Obstet Gynecol Scand. 2020;99(8):966–9.
Sundblad C, Landén M, Eriksson T, Bergman L, Eriksson E. Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa: a placebo-controlled pilot study. J Clin Psychopharmacol. 2005;25(1):85–8.
Naessén S, Carlström K, Byström B, Pierre Y, Hirschberg AL. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women. Psychoneuroendocrinology. 2007;32(5):548–54.
Robinson L, Aldridge V, Clark EM, Misra M, Micali N. A systematic review and meta-analysis of the association between eating disorders and bone density. Osteoporos Int. 2016;27(6):1953–66.
Hagan KE, Walsh BT. State of the art: the therapeutic approaches to bulimia nervosa. Clin Ther. 2021;43(1):40–9.
Slade E, Keeney E, Mavranezouli I, Dias S, Fou L, Stockton S, Saxon L, Waller G, Turner H, Serpell L, Fairburn CG, Kendall T. Treatments for bulimia nervosa: a network meta-analysis. Psychol Med. 2018;48:2629–36.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 International Society of Gynecological Endocrinology
About this chapter
Cite this chapter
Hirschberg, A.L. (2023). Amenorrhea in Eating Disorders. In: Genazzani, A.R., Hirschberg, A.L., Genazzani, A.D., Nappi, R., Vujovic, S. (eds) Amenorrhea. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-031-22378-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-22378-5_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-22377-8
Online ISBN: 978-3-031-22378-5
eBook Packages: MedicineMedicine (R0)